 The law firm of Kessler Topaz Meltzer Check, LLP reminds Chembio Diagnostics, Inc. NASDAQ: CEMI Chembio investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or otherwise acquired Chembio common stock between March 12, 2020 and June 16, 2020, inclusive the Class Period. 